Purchase Order 75N93020P00199

Award Date 1/3/20
Potential Completion Date 6/3/20
Potential Value $59K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $9,606 firm-fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of biotechnology products. The contract is for the provision of laboratory equipment, with a completion date of December 7, 2014. This award is set aside for small businesses. Miltenyi Biotec is a global biotechnology company that supplies specialized scientific...
This is a $11,648.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to EMD Millipore Corp, a foreign-owned manufacturer of laboratory products and services. The contract is for the supply of a 23-plex cytokine magnetic bead panel, which is used in biomedical research, drug development, and testing across federal agencies like the NIH, CDC, DoD, and FDA. EMD Millipore Corp is...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a firm fixed price purchase order to SPT Labtech LIMITED, a foreign-owned for-profit manufacturer located in Great Britain. The $160,640.81 contract is for the company's Firefly and Dragonfly liquid handling systems, associated consumables, and related software, maintenance, and support services. This acquisition was conducted using Simplified Acquisition...
This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit organization, in the amount of $113,936.00. The award is for the delivery of Olink's integrated fluidic circuits and reagent kits to support the Viral Pathogenesis and Evolution Section's research into the development of universal influenza and SARS-CoV-2 vaccines. The...
This is a $10,080.00 firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to EMD Millipore Corp, a foreign-owned, for-profit manufacturer of laboratory products and services. The contract is to provide a MILLIPLEX Non-Human Primate Cytokine/Chemokine Magnetic Bead Premixed 23-Plex Panel, which is used in biomedical research, drug development, and testing programs. EMD Millipore Corp is an established federal contractor, holding several...
This is a firm fixed price purchase order for $34,902.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Olink Proteomics AB, a foreign-owned for-profit entity based in Sweden. The contract is for the delivery of Olink Proteomics' proprietary Inflammation reagent kits and Dynamic Array chips, which support multiplex protein biomarker analysis. This purchase order was awarded under simplified acquisition procedures...
The Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Formulatrix, LLC, a foreign-owned for-profit organization, on April 30, 2018. The $79,921.50 contract provides specialized laboratory automation solutions and scientific equipment to support biomedical research efforts, including automated liquid handling systems, protein crystallization imagers and robots,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to EMD Millipore Corp, a foreign-owned manufacturer of laboratory products and services. The $58,896.50 fixed-price purchase order is for an ARRA-funded MILLIPLEX NON-HUMAN PRIMATE CYTOKINE PREMIXED 23 PLEX IMMUNOASSAY KIT to support biomedical research. EMD Millipore Corp, also known as Milliporesigma, has a long history of providing...

Mologic Inc., a foreign-owned for-profit organization located in Great Britain, was awarded a $59,010 firm fixed price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The purchase order, which had no set-aside designation and was completed on June 3, 2020, was for custom antibody development in support of NIAID's biomedical research mission. As a leading developer of lateral flow immunoassay tests, Mologic Inc. utilizes its expertise in immunodiagnostics to provide specialized services that facilitate NIH's goal of improving public health through innovative disease detection and treatment.

Generated 2/2/24, 9:40 AM